{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T22:27:41Z","timestamp":1792794461359,"version":"4.5.0"},"reference-count":79,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2024,9,21]],"date-time":"2024-09-21T00:00:00Z","timestamp":1726876800000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"International Evidence-based Guideline in PCOS"},{"name":"Centre for Research Excellence for Women's Health in Reproductive Life","award":["APP1171592"],"award-info":[{"award-number":["APP1171592"]}]},{"name":"CRE in Polycystic Ovary Syndrome","award":["APP1078444"],"award-info":[{"award-number":["APP1078444"]}]},{"DOI":"10.13039\/501100001779","name":"Monash University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001779","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002603","name":"The American Society for Reproductive Medicine","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100002603","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100005709","name":"Endocrine Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005709","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010382","name":"European Society of Endocrinology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010382","id-type":"DOI","asserted-by":"publisher"}]},{"name":"European Society of Human Reproduction and Embryology","id":[{"id":"https:\/\/ror.org\/028sbah75","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Monash Graduate Scholarship"},{"name":"Monash International Tuition Scholarship"},{"DOI":"10.13039\/501100000925","name":"NHMRC","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["WT209492\/Z\/17\/Z"],"award-info":[{"award-number":["WT209492\/Z\/17\/Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018645","name":"MRC","doi-asserted-by":"publisher","award":["MC_UP_1605\/15"],"award-info":[{"award-number":["MC_UP_1605\/15"]}],"id":[{"id":"10.13039\/100018645","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Clinical Research Training"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,1,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>BACKGROUND<\/jats:title>\n                    <jats:p>Biochemical hyperandrogenism is a hallmark and diagnostic feature of polycystic ovary syndrome (PCOS). However, the most accurate androgen measurement for assessing biochemical hyperandrogenism in PCOS diagnosis remains uncertain.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>OBJECTIVE AND RATIONALE<\/jats:title>\n                    <jats:p>This systematic review aimed to assess different androgen measures [including total testosterone (TT), calculated free testosterone (cFT), free androgen index (FAI), androstenedione (A4), dehydroepiandrosterone sulfate (DHEAS), and dihydrotestosterone (DHT)] for accuracy in diagnosing biochemical hyperandrogenism in women with PCOS, to inform the 2023 International PCOS Evidence-based Guidelines.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>SEARCH METHODS<\/jats:title>\n                    <jats:p>To update evidence from the 2018 International PCOS Guidelines, a systematic search from 3 July 2017 to 23 June 2023 was conducted across Medline (Ovid), CINAHL, all EBM, EMBASE, and PsycInfo for articles evaluating androgens in the diagnosis of biochemical hyperandrogenism. The revised Quality Assessment of Diagnostic Accuracy Studies (QUADAS-2) was used to assess the risk of bias and applicability. A diagnostic test accuracy meta-analysis was performed using STATA 18 software. Summary sensitivity and specificity were calculated with 95% CIs using the bivariate model, while the hierarchical summary receiver operating characteristics (ROC) model was used to produce a summary ROC curve.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>OUTCOMES<\/jats:title>\n                    <jats:p>Of 23 studies reviewed, 18 were included in the meta-analysis, with data from 2857 participants (1650 with PCOS and 1207 controls). For diagnosing biochemical hyperandrogenism in PCOS, the pooled sensitivity, specificity, and AUC with 95% CI were for TT: 0.74 (0.63\u20130.82), 0.86 (0.77\u20130.91), and 0.87 (0.84\u20130.90); cFT: 0.89 (0.69\u20130.96), 0.83 (0.79\u20130.86), and 0.85 (0.81\u20130.88); FAI: 0.78 (0.70\u20130.83), 0.85 (0.76\u20130.90), and 0.87 (0.84\u20130.90); A4: 0.75 (0.60\u20130.86), 0.71 (0.51\u20130.85), and 0.80 (0.76\u20130.83); and DHEAS: 0.75 (0.61\u20130.85), 0.67 (0.48\u20130.81), and 0.77 (0.73\u20130.81), respectively. In subgroup analyses, liquid chromatography with tandem mass spectrometry (LC-MS\/MS) had superior sensitivity for measuring cFT, FAI, A4, and DHEAS, and superior specificity for measuring TT, cFT, and FAI, compared to the direct immunoassay method.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>WIDER IMPLICATIONS<\/jats:title>\n                    <jats:p>Our results directly informed the 2023 International PCOS Guideline recommendations to use TT and FT as the first-line laboratory tests to assess biochemical hyperandrogenism in the diagnosis of PCOS. cFT should be assessed by equilibrium dialysis or ammonium sulfate precipitation, or calculated using FAI. If TT or cFT are not elevated, A4 and DHEAS could also be considered, noting their poorer specificity. Laboratories should utilize LC-MS\/MS for androgen measurement given its high accuracy. Future studies should focus on establishing optimal normative cut-off values in large, unselected, and ethnically diverse cohorts of women.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>REGISTRATION NUMBER<\/jats:title>\n                    <jats:p>The review protocol was prepublished in the 2023 PCOS Guideline Technical Report (https:\/\/www.monash.edu\/__data\/assets\/pdf_file\/0010\/3379591\/TechnicalReport-2023.pdf).<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/humupd\/dmae028","type":"journal-article","created":{"date-parts":[[2024,8,29]],"date-time":"2024-08-29T20:45:24Z","timestamp":1724964324000},"page":"48-63","source":"Crossref","is-referenced-by-count":48,"title":["Evaluating the diagnostic accuracy of androgen measurement in polycystic ovary syndrome: a systematic review and diagnostic meta-analysis to inform evidence-based guidelines"],"prefix":"10.1093","volume":"31","author":[{"given":"Asmamaw Demis","family":"Bizuneh","sequence":"first","affiliation":[{"name":"Monash Centre for Health Research and Implementation, Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, VIC ,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6307-2568","authenticated-orcid":false,"given":"Anju E","family":"Joham","sequence":"additional","affiliation":[{"name":"Monash Centre for Health Research and Implementation, Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, VIC ,","place":["Australia"]},{"name":"Department of Endocrinology and Diabetes, Monash Health, Clayton , Melbourne, VIC,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7609-577X","authenticated-orcid":false,"given":"Helena","family":"Teede","sequence":"additional","affiliation":[{"name":"Monash Centre for Health Research and Implementation, Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, VIC ,","place":["Australia"]},{"name":"Department of Endocrinology and Diabetes, Monash Health, Clayton , Melbourne, VIC,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7356-4523","authenticated-orcid":false,"given":"Aya","family":"Mousa","sequence":"additional","affiliation":[{"name":"Monash Centre for Health Research and Implementation, Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, VIC ,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arul","family":"Earnest","sequence":"additional","affiliation":[{"name":"School of Public Health and Preventive Medicine, Monash University , Melbourne, VIC,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James M","family":"Hawley","sequence":"additional","affiliation":[{"name":"Department of Clinical Biochemistry, Wythenshawe Hospital, Manchester University NHS Foundation Trust , Manchester,","place":["UK"]},{"name":"Medical Research Council, Laboratory of Medical Sciences, London ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Smith","sequence":"additional","affiliation":[{"name":"School of Medical, Indigenous and Health Sciences, Illawarra Health and Medical Research Institute, University of Wollongong, Wollongong, NSW ,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo","family":"Azziz","sequence":"additional","affiliation":[{"name":"Department of Obstetrics & Gynecology, and Medicine University of Alabama at Birmingham, Birmingham, AL ,","place":["USA"]},{"name":"Department of Medicine, University of Alabama at Birmingham , Birmingham, AL,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wiebke","family":"Arlt","sequence":"additional","affiliation":[{"name":"Medical Research Council, Laboratory of Medical Sciences, London ,","place":["UK"]},{"name":"Institute of Metabolism and Systems Research, University of Birmingham , Birmingham,","place":["UK"]},{"name":"Institute of Clinical Sciences, Imperial College London , London,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6228-2654","authenticated-orcid":false,"given":"Chau Thien","family":"Tay","sequence":"additional","affiliation":[{"name":"Monash Centre for Health Research and Implementation, Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, VIC ,","place":["Australia"]},{"name":"Department of Endocrinology and Diabetes, Monash Health, Clayton , Melbourne, VIC,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,9,20]]},"reference":[{"key":"2025010312410151300_dmae028-B1","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1515\/hmbci-2016-0047","article-title":"Hyperandrogenemia in women with polycystic ovary syndrome: prevalence, characteristics and association with body mass index","volume":"29","author":"Alexiou","year":"2017","journal-title":"Horm Mol Biol Clin Investig"},{"key":"2025010312410151300_dmae028-B2","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1056\/NEJM199909303411401","article-title":"Dehydroepiandrosterone replacement in women with adrenal insufficiency","volume":"341","author":"Arlt","year":"1999","journal-title":"N Engl J Med"},{"key":"2025010312410151300_dmae028-B3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s43042-019-0031-4","article-title":"Hyperandrogenism in polycystic ovarian syndrome and role of CYP gene variants: a review","volume":"20","author":"Ashraf","year":"2019","journal-title":"Egypt J Med Hum Genet"},{"key":"2025010312410151300_dmae028-B4","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1097\/AOG.0000000000002698","article-title":"Polycystic ovary syndrome","volume":"132","author":"Azziz","year":"2018","journal-title":"Obstet Gynecol"},{"key":"2025010312410151300_dmae028-B5","doi-asserted-by":"crossref","first-page":"4237","DOI":"10.1210\/jc.2006-0178","article-title":"Criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an androgen excess society guideline","volume":"91","author":"Azziz","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"2025010312410151300_dmae028-B6","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.fertnstert.2008.06.035","article-title":"The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report","volume":"91","author":"Azziz","year":"2009","journal-title":"Fertil Steril"},{"key":"2025010312410151300_dmae028-B7","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1210\/jc.2003-031122","article-title":"Androgen excess in women: experience with over 1000 consecutive patients","volume":"89","author":"Azziz","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"2025010312410151300_dmae028-B8","doi-asserted-by":"crossref","first-page":"e13974","DOI":"10.1111\/dth.13974","article-title":"A prospective study of anti-mullerian hormone and other ovarian and adrenal hormones in adult female acne","volume":"33","author":"Bansal","year":"2020","journal-title":"Dermatol Ther"},{"key":"2025010312410151300_dmae028-B9","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1530\/EJE-09-0741","article-title":"Defining hyperandrogenism in polycystic ovary syndrome: measurement of testosterone and androstenedione by liquid chromatography-tandem mass spectrometry and analysis by receiver operator characteristic plots","volume":"162","author":"Barth","year":"2010","journal-title":"Eur J Endocrinol"},{"key":"2025010312410151300_dmae028-B10","doi-asserted-by":"crossref","first-page":"904706","DOI":"10.3389\/fendo.2022.904706","article-title":"Polycystic ovary syndrome phenotype D versus functional hypothalamic amenorrhea with polycystic ovarian morphology: a retrospective study about a frequent differential diagnosis","volume":"13","author":"Beitl","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2025010312410151300_dmae028-B11","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.ejogrb.2014.05.006","article-title":"The combination of ovarian volume and outline has better diagnostic accuracy than prostate-specific antigen (PSA) concentrations in women with polycystic ovarian syndrome (PCOs)","volume":"179","author":"Bili","year":"2014","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"2025010312410151300_dmae028-B12","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1097\/XEB.0000000000000061","article-title":"Diagnostic test accuracy: methods for systematic review and meta-analysis","volume":"13","author":"Campbell","year":"2015","journal-title":"Int J Evid Based Healthc"},{"key":"2025010312410151300_dmae028-B13","doi-asserted-by":"crossref","first-page":"e23539","DOI":"10.1002\/jcla.23539","article-title":"Simultaneous quantitation of four androgens and 17-hydroxyprogesterone in polycystic ovarian syndrome patients by LC-MS\/MS","volume":"34","author":"Cao","year":"2020","journal-title":"J Clin Lab Anal"},{"key":"2025010312410151300_dmae028-B14","doi-asserted-by":"crossref","first-page":"3255","DOI":"10.3390\/cells11203255","article-title":"Increased prevalence of elevated DHEAS in PCOS women with non-classic (B or C) phenotypes: a retrospective analysis in patients aged 20 to 29 years","volume":"11","author":"Carmina","year":"2022","journal-title":"Cells"},{"key":"2025010312410151300_dmae028-B15","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s13048-021-00781-5","article-title":"Comparison of the efficacy of different androgens measured by LC-MS\/MS in representing hyperandrogenemia and an evaluation of adrenal-origin androgens with a dexamethasone suppression test in patients with PCOS","volume":"14","author":"Chen","year":"2021","journal-title":"J Ovarian Res"},{"key":"2025010312410151300_dmae028-B16","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.jclinepi.2005.01.016","article-title":"The performance of tests of publication bias and other sample size effects in systematic reviews of diagnostic test accuracy was assessed","volume":"58","author":"Deeks","year":"2005","journal-title":"J Clin Epidemiol"},{"key":"2025010312410151300_dmae028-B17","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1471-2288-2-9","article-title":"Conducting systematic reviews of diagnostic studies: didactic guidelines","volume":"2","author":"Devill\u00e9","year":"2002","journal-title":"BMC Med Res Methodol"},{"key":"2025010312410151300_dmae028-B18","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1515\/cclm-2016-1124","article-title":"Serum complexed and free prostate-specific antigen (PSA) for the diagnosis of the polycystic ovarian syndrome (PCOS)","volume":"55","author":"Diamandis","year":"2017","journal-title":"Clin Chem Lab Med"},{"key":"2025010312410151300_dmae028-B19","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1210\/jc.2017-02426","article-title":"Causes, patterns, and severity of androgen excess in 1205 consecutively recruited women","volume":"103","author":"Elhassan","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"2025010312410151300_dmae028-B20","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1530\/eje.0.1450619","article-title":"Receiver operating characteristic analysis of the performance of basal serum hormone profiles for the diagnosis of polycystic ovary syndrome in epidemiological studies","volume":"145","author":"Escobar-Morreale","year":"2001","journal-title":"Eur J Endocrinol"},{"key":"2025010312410151300_dmae028-B21","doi-asserted-by":"crossref","first-page":"E1088","DOI":"10.1210\/jc.2013-1295","article-title":"Referral bias in defining the phenotype and prevalence of obesity in polycystic ovary syndrome","volume":"98","author":"Ezeh","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"2025010312410151300_dmae028-B22","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.jsbmb.2014.06.003","article-title":"DHEA, DHEAS and PCOS","volume":"145","author":"Goodarzi","year":"2015","journal-title":"J Steroid Biochem Mol Biol"},{"key":"2025010312410151300_dmae028-B23","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.4158\/EP15748.DSC","article-title":"American Association of Clinical Endocrinologists, American College of Endocrinology, and androgen excess and PCOS society disease state clinical review: guide to the best practices in the evaluation and treatment of polycystic ovary syndrome\u2014part 1","volume":"21","author":"Goodman","year":"2015","journal-title":"Endocr Pract"},{"key":"2025010312410151300_dmae028-B24","doi-asserted-by":"crossref","first-page":"119","DOI":"10.3390\/jcm10010119","article-title":"Hyperandrogenism by liquid chromatography tandem mass spectrometry in PCOS: focus on testosterone and androstenedione","volume":"10","author":"Grassi","year":"2020","journal-title":"J Clin Med"},{"key":"2025010312410151300_dmae028-B25","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1210\/jc.2007-1134","article-title":"Long-term DHEA replacement in primary adrenal insufficiency: a randomized, controlled trial","volume":"93","author":"Gurnell","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"2025010312410151300_dmae028-B26","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1515\/CCLM.2007.031","article-title":"Diagnostic value of calculated testosterone indices in the assessment of polycystic ovary syndrome","volume":"45","author":"Hahn","year":"2007","journal-title":"Clin Chem Lab Med"},{"key":"2025010312410151300_dmae028-B27","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1177\/1536867X0900900203","article-title":"Metandi: meta-analysis of diagnostic accuracy using hierarchical logistic regression","volume":"9","author":"Harbord","year":"2009","journal-title":"Stata J"},{"key":"2025010312410151300_dmae028-B28","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1016\/j.fertnstert.2008.12.138","article-title":"Prevalence of hyperandrogenemia in the polycystic ovary syndrome diagnosed by the National Institutes of Health 1990 criteria","volume":"93","author":"Huang","year":"2010","journal-title":"Fertil Steril"},{"key":"2025010312410151300_dmae028-B29","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.13005\/bpj\/2056","article-title":"Testosterone or dehydroepiandrosterone sulfate as a biomarker for hirsutism in women with polycystic ovary syndrome","volume":"13","author":"Imran","year":"2020","journal-title":"Biomed Pharmacol J"},{"key":"2025010312410151300_dmae028-B30","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1530\/EJE-11-0482","article-title":"Assessment of androgen concentration in women: liquid chromatography-tandem mass spectrometry and extraction RIA show comparable results","volume":"165","author":"Janse","year":"2011","journal-title":"Eur J Endocrinol"},{"key":"2025010312410151300_dmae028-B31","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.cca.2017.10.030","article-title":"The simultaneous measurement of serum testosterone and 5alpha-dihydrotestosterone by gas chromatography-mass spectrometry (GC-MS)","volume":"476","author":"Kannenberg","year":"2018","journal-title":"Clin Chim Acta"},{"key":"2025010312410151300_dmae028-B32","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.beem.2013.05.015","article-title":"Novel liquid chromatography tandem mass spectrometry (LC-MS\/MS) methods for measuring steroids","volume":"27","author":"Keevil","year":"2013","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"2025010312410151300_dmae028-B33","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1111\/cen.13561","article-title":"The free androgen index is inaccurate in women when the SHBG concentration is low","volume":"88","author":"Keevil","year":"2018","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2025010312410151300_dmae028-B34","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.3390\/jcm9061831","article-title":"The relevant hormonal levels and diagnostic features of polycystic ovary syndrome in adolescents","volume":"9","author":"Khashchenko","year":"2020","journal-title":"J Clin Med"},{"key":"2025010312410151300_dmae028-B35","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S0015-0282(16)58146-1","article-title":"Optimal use of hormone determinations in the biochemical diagnosis of the polycystic ovary syndrome","volume":"65","author":"Koskinen","year":"1996","journal-title":"Fertil Steril"},{"key":"2025010312410151300_dmae028-B36","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1111\/j.1365-2265.2005.02256.x","article-title":"Prevalence of adrenal androgen excess in patients with the polycystic ovary syndrome (PCOS)","volume":"62","author":"Kumar","year":"2005","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2025010312410151300_dmae028-B37","first-page":"9","article-title":"Dihydrotestosterone\u2014a potential biomarker of hyperandrogenaemia in polycystic ovary syndrome: a case-control study from North India","volume":"16","author":"Kumar","year":"2022","journal-title":"J Clin Diagn Res"},{"key":"2025010312410151300_dmae028-B38","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1006\/frne.2001.0216","article-title":"DHEA and its transformation into androgens and estrogens in peripheral target tissues: intracrinology","volume":"22","author":"Labrie","year":"2001","journal-title":"Front Neuroendocrinol"},{"key":"2025010312410151300_dmae028-B39","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.3348\/kjr.2015.16.6.1188","article-title":"Systematic review and meta-analysis of studies evaluating diagnostic test accuracy: a practical review for clinical researchers\u2014part II. Statistical methods of meta-analysis","volume":"16","author":"Lee","year":"2015","journal-title":"Korean J Radiol"},{"key":"2025010312410151300_dmae028-B40","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.fertnstert.2016.05.003","article-title":"Criteria, prevalence, and phenotypes of polycystic ovary syndrome","volume":"106","author":"Lizneva","year":"2016","journal-title":"Fertil Steril"},{"key":"2025010312410151300_dmae028-B41","doi-asserted-by":"crossref","first-page":"e13029","DOI":"10.1111\/eci.13029","article-title":"Certified testosterone immunoassays for hyperandrogenaemia","volume":"48","author":"Luque-Ramirez","year":"2018","journal-title":"Eur J Clin Invest"},{"key":"2025010312410151300_dmae028-B42","volume-title":"Cochrane Handbook for Systematic Reviews of Diagnostic Test Accuracy Version 1.0. The Cochrane Collaboration,","author":"Macaskill","year":"2010"},{"key":"2025010312410151300_dmae028-B43","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1093\/humrep\/dep399","article-title":"The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria","volume":"25","author":"March","year":"2010","journal-title":"Hum Reprod"},{"key":"2025010312410151300_dmae028-B44","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1258\/acb.2012.012159","article-title":"Clinical biochemistry of dihydrotestosterone","volume":"50","author":"Marchetti","year":"2013","journal-title":"Ann Clin Biochem"},{"key":"2025010312410151300_dmae028-B45","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1001\/jama.2017.19163","article-title":"Preferred reporting items for a systematic review and meta-analysis of diagnostic test accuracy studies: the PRISMA-DTA statement","volume":"319","author":"McInnes","year":"2018","journal-title":"JAMA"},{"key":"2025010312410151300_dmae028-B46","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1210\/jc.2003-030680","article-title":"Measurement of free testosterone in normal women and women with androgen deficiency: comparison of methods","volume":"89","author":"Miller","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"2025010312410151300_dmae028-B47","author":"Mousa","year":"2023"},{"key":"2025010312410151300_dmae028-B48","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1055\/s-2006-924062","article-title":"Is it necessary to measure free testosterone to assess hyperandrogenemia in women? The role of calculated free and bioavailable testosterone","volume":"114","author":"Mueller","year":"2006","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"2025010312410151300_dmae028-B49","first-page":"33","article-title":"Establishing the cut off values of androgen markers in the assessment of polycystic ovarian syndrome","volume":"40","author":"Nadaraja","year":"2018","journal-title":"Malays J Pathol"},{"key":"2025010312410151300_dmae028-B50","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1210\/jc.2013-3399","article-title":"Hyperandrogenemia predicts metabolic phenotype in polycystic ovary syndrome: the utility of serum androstenedione","volume":"99","author":"O\u2019Reilly","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"2025010312410151300_dmae028-B51","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1258\/acb.2012.012037","article-title":"Testosterone measurement by liquid chromatography tandem mass spectrometry: the importance of internal standard choice","volume":"49","author":"Owen","year":"2012","journal-title":"Ann Clin Biochem"},{"key":"2025010312410151300_dmae028-B52","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1177\/0004563215621096","article-title":"A direct assay for the routine measurement of testosterone, androstenedione, dihydrotestosterone and dehydroepiandrosterone by liquid chromatography tandem mass spectrometry","volume":"53","author":"Owen","year":"2016","journal-title":"Ann Clin Biochem"},{"key":"2025010312410151300_dmae028-B53","doi-asserted-by":"crossref","first-page":"105906","DOI":"10.1016\/j.ijsu.2021.105906","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"88","author":"Page","year":"2021","journal-title":"Int J Surg"},{"key":"2025010312410151300_dmae028-B54","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/j.jclinepi.2005.02.022","article-title":"Bivariate analysis of sensitivity and specificity produces informative summary measures in diagnostic reviews","volume":"58","author":"Reitsma","year":"2005","journal-title":"J Clin Epidemiol"},{"key":"2025010312410151300_dmae028-B55","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1210\/er.2015-1104","article-title":"The pathogenesis of polycystic ovary syndrome (PCOS): the hypothesis of PCOS as functional ovarian hyperandrogenism revisited","volume":"37","author":"Rosenfield","year":"2016","journal-title":"Endocr Rev"},{"key":"2025010312410151300_dmae028-B56","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1210\/jc.2006-1864","article-title":"Limitations, and pitfalls in measuring testosterone: an endocrine society position statement","volume":"92","author":"Rosner","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"2025010312410151300_dmae028-B57","doi-asserted-by":"crossref","first-page":"4542","DOI":"10.1210\/jc.2010-1314","article-title":"Toward excellence in testosterone testing: a consensus statement","volume":"95","author":"Rosner","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"2025010312410151300_dmae028-B58","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/humrep\/deh098","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)","volume":"19","author":"Rotterdam ESHRE ASRM-Sponsored PCOS Consensus Workshop Group","year":"2004","journal-title":"Hum Reprod"},{"key":"2025010312410151300_dmae028-B59","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1080\/09513590.2016.1200552","article-title":"Prostate specific antigen (PSA) in diagnosis of polycystic ovarian syndrome\u2013a new insight","volume":"32","author":"Rudnicka","year":"2016","journal-title":"Gynecol Endocrinol"},{"key":"2025010312410151300_dmae028-B60","doi-asserted-by":"crossref","first-page":"2865","DOI":"10.1002\/sim.942","article-title":"A hierarchical regression approach to meta-analysis of diagnostic test accuracy evaluations","volume":"20","author":"Rutter","year":"2001","journal-title":"Stat Med"},{"key":"2025010312410151300_dmae028-B61","doi-asserted-by":"crossref","first-page":"m2632","DOI":"10.1136\/bmj.m2632","article-title":"Preferred reporting items for systematic review and meta-analysis of diagnostic test accuracy studies (PRISMA-DTA): explanation, elaboration, and checklist","volume":"370","author":"Salameh","year":"2020","journal-title":"BMJ"},{"key":"2025010312410151300_dmae028-B62","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/j.fertnstert.2013.12.056","article-title":"Specificity and predictive value of circulating testosterone assessed by tandem mass spectrometry for the diagnosis of polycystic ovary syndrome by the National Institutes of Health 1990 criteria","volume":"101","author":"Salameh","year":"2014","journal-title":"Fertil Steril"},{"key":"2025010312410151300_dmae028-B63","doi-asserted-by":"crossref","first-page":"3589","DOI":"10.1038\/s41598-017-03945-w","article-title":"Salivary testosterone measurement in women with and without polycystic ovary syndrome","volume":"7","author":"Sathyapalan","year":"2017","journal-title":"Sci Rep"},{"key":"2025010312410151300_dmae028-B64","first-page":"203","article-title":"Measures of diagnostic accuracy: basic definitions","volume":"19","author":"Simundic","year":"2009","journal-title":"EJIFCC"},{"key":"2025010312410151300_dmae028-B65","volume-title":"Stata Statistical Software: Release 18 (2023)","author":"StataCorp","year":"2023"},{"key":"2025010312410151300_dmae028-B66","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1210\/jc.2009-1908","article-title":"Are there any sensitive and specific sex steroid markers for polycystic ovary syndrome?","volume":"95","author":"Stener-Victorin","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"2025010312410151300_dmae028-B67","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1373\/49.8.1381","article-title":"Testosterone measured by 10 immunoassays and by isotope-dilution gas chromatography-mass spectrometry in sera from 116 men, women, and children","volume":"49","author":"Taieb","year":"2003","journal-title":"Clin Chem"},{"key":"2025010312410151300_dmae028-B68","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/1741-7015-8-41","article-title":"Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan","volume":"8","author":"Teede","year":"2010","journal-title":"BMC Med"},{"key":"2025010312410151300_dmae028-B69","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1093\/humrep\/dey256","article-title":"Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome","volume":"33","author":"Teede","year":"2018","journal-title":"Hum Reprod"},{"key":"2025010312410151300_dmae028-B70","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.1210\/clinem\/dgad463","article-title":"Recommendations from the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome","volume":"108","author":"Teede","year":"2023","journal-title":"J Clin Endocrinol Metab"},{"key":"2025010312410151300_dmae028-B71","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/1471-2288-14-70","article-title":"Investigation of publication bias in meta-analyses of diagnostic test accuracy: a meta-epidemiological study","volume":"14","author":"van Enst","year":"2014","journal-title":"BMC Med Res Methodol"},{"key":"2025010312410151300_dmae028-B72","doi-asserted-by":"crossref","first-page":"3666","DOI":"10.1210\/jcem.84.10.6079","article-title":"A critical evaluation of simple methods for the estimation of free testosterone in serum","volume":"84","author":"Vermeulen","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"2025010312410151300_dmae028-B73","doi-asserted-by":"crossref","first-page":"625","DOI":"10.3109\/09513590.2015.1025380","article-title":"Hirsutism and oligomenorrhea are appropriate screening criteria for polycystic ovary syndrome in adolescents","volume":"31","author":"Villarroel","year":"2015","journal-title":"Gynecol Endocrinol"},{"key":"2025010312410151300_dmae028-B74","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1111\/jog.14681","article-title":"The value of serum-free androgen index in the diagnosis of polycystic ovary syndrome: a systematic review and meta-analysis","volume":"47","author":"Wang","year":"2021","journal-title":"J Obstet Gynaecol Res"},{"key":"2025010312410151300_dmae028-B75","doi-asserted-by":"crossref","first-page":"529","DOI":"10.7326\/0003-4819-155-8-201110180-00009","article-title":"QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies","volume":"155","author":"Whiting","year":"2011","journal-title":"Ann Intern Med"},{"key":"2025010312410151300_dmae028-B76","doi-asserted-by":"crossref","first-page":"e24739","DOI":"10.1002\/jcla.24739","article-title":"Diagnostic value of total testosterone and free androgen index measured by LC-MS\/MS for PCOS and insulin resistance","volume":"36","author":"Xu","year":"2022","journal-title":"J Clin Lab Anal"},{"key":"2025010312410151300_dmae028-B77","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.7326\/M21-2234","article-title":"QUADAS-C: a tool for assessing risk of bias in comparative diagnostic accuracy studies","volume":"174","author":"Yang","year":"2021","journal-title":"Ann Intern Med"},{"key":"2025010312410151300_dmae028-B78","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.eprac.2023.05.007","article-title":"A model combining testosterone, androstenedione and free testosterone index improved the diagnostic efficiency of polycystic ovary syndrome","volume":"29","author":"Yi","year":"2023","journal-title":"Endocr Pract"},{"key":"2025010312410151300_dmae028-B79","first-page":"377","article-title":"Diagnostic criteria for polycystic ovary syndrome: towards a rational approach","author":"Zawadski","year":"1992","journal-title":"Polycystic Ovary Syndrome"}],"container-title":["Human Reproduction Update"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/humupd\/article-pdf\/31\/1\/48\/59215154\/dmae028.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/humupd\/article-pdf\/31\/1\/48\/59215154\/dmae028.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,3]],"date-time":"2025-01-03T07:41:46Z","timestamp":1735890106000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/humupd\/article\/31\/1\/48\/7762932"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,20]]},"references-count":79,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,9,20]]},"published-print":{"date-parts":[[2025,1,1]]}},"URL":"https:\/\/doi.org\/10.1093\/humupd\/dmae028","relation":{},"ISSN":["1355-4786","1460-2369"],"issn-type":[{"value":"1355-4786","type":"print"},{"value":"1460-2369","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,1]]},"published":{"date-parts":[[2024,9,20]]}}}